Drugs interactions for Mounjaro®
- 0 Major drug interactions
- 258 Moderate drug interactions (including ingredients like Acarbose, Acebutolol, Acetylsalicylic acid)
- 38 Minor drug interactions (including ingredients like Acetazolamide, Acetyl sulfisoxazole, Albuterol)
296 interactions for Mounjaro®The risk or severity of hypoglycemia can be increased when Acarbose is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Acebutolol.The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Alogliptin is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Tirzepatide.Aminosalicylic acid may increase the hypoglycemic activities of Tirzepatide.The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Tirzepatide.Amitriptyline may decrease the hypoglycemic activities of Tirzepatide.The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Tirzepatide.Amoxapine may decrease the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Aripiprazole.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Arsenic trioxide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Articaine.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Asenapine.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Atazanavir.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Atenolol.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Baclofen.Balsalazide may increase the hypoglycemic activities of Tirzepatide.The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Benazepril is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Bendroflumethiazide.The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Betaxolol.Bexagliflozin may increase the hypoglycemic activities of Tirzepatide.Bismuth subsalicylate may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Bisoprolol.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Brexpiprazole.The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Budesonide is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Bumetanide.Canagliflozin may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Carvedilol.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Ceritinib.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Chlorothiazide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Chlorpromazine.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Chlorthalidone.Choline salicylate may increase the hypoglycemic activities of Tirzepatide.The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Ciprofloxacin.The risk or severity of hypoglycemia can be increased when Citalopram is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Tirzepatide.Clomipramine may decrease the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Clozapine.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Conjugated estrogens.The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Dabrafenib.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Danazol.Dapagliflozin may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Darunavir.The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Delafloxacin.Desipramine may decrease the hypoglycemic activities of Tirzepatide.Tirzepatide can cause a decrease in the absorption of Desogestrel resulting in a reduced serum concentration and potentially a decrease in efficacy.The risk or severity of hyperglycemia can be increased when Desonide is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Desvenlafaxine is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Diazoxide.Tirzepatide can cause a decrease in the absorption of Dienogest resulting in a reduced serum concentration and potentially a decrease in efficacy.The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Tirzepatide.Diflunisal may increase the hypoglycemic activities of Tirzepatide.The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Tirzepatide.Doxepin may decrease the hypoglycemic activities of Tirzepatide.Tirzepatide can cause a decrease in the absorption of Drospirenone resulting in a reduced serum concentration and potentially a decrease in efficacy.The risk or severity of hypoglycemia can be increased when Dulaglutide is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Duloxetine is combined with Tirzepatide.Empagliflozin may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Epinephrine.Ertugliflozin may increase the hypoglycemic activities of Tirzepatide.The risk or severity of hypoglycemia can be increased when Escitalopram is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Estetrol.Tirzepatide can cause a decrease in the absorption of Estradiol resulting in a reduced serum concentration and potentially a decrease in efficacy.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Estrone sulfate.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Etacrynic acid.Tirzepatide can cause a decrease in the absorption of Ethinylestradiol resulting in a reduced serum concentration and potentially a decrease in efficacy.The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Tirzepatide.Tirzepatide can cause a decrease in the absorption of Ethynodiol diacetate resulting in a reduced serum concentration and potentially a decrease in efficacy.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Etonogestrel.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Everolimus.The risk or severity of hypoglycemia can be increased when Exenatide is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Felodipine is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Tirzepatide is combined with Fluconazole.The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Fluoxetine is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Fosamprenavir.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Furosemide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Gatifloxacin.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Gemifloxacin.Tirzepatide can cause a decrease in the absorption of Gestodene resulting in a reduced serum concentration and potentially a decrease in efficacy.The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Glipizide is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Glyburide is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Goserelin.The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Haloperidol.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Histrelin.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Hydrochlorothiazide.The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Hydroflumethiazide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Hydroxychloroquine.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Hydroxyprogesterone caproate.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Iloperidone.Imipramine may decrease the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Indapamide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Indinavir.The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Insulin aspart is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Insulin degludec is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Insulin detemir is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Insulin glulisine is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Insulin human is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Isoniazid.The risk or severity of hypoglycemia can be increased when Isradipine is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Labetalol.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Lanreotide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Leuprolide.The risk or severity of hypoglycemia can be increased when Levamlodipine is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Levofloxacin.The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Tirzepatide.Tirzepatide can cause a decrease in the absorption of Levonorgestrel resulting in a reduced serum concentration and potentially a decrease in efficacy.The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Liothyronine.The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Lixisenatide is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Lomefloxacin.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Lonapegsomatropin.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Lopinavir.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Lurasidone.The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Tirzepatide.Tirzepatide can cause a decrease in the absorption of Medroxyprogesterone acetate resulting in a reduced serum concentration and potentially a decrease in efficacy.The risk or severity of hyperglycemia can be increased when Medrysone is combined with Tirzepatide.Tirzepatide can cause a decrease in the absorption of Megestrol acetate resulting in a reduced serum concentration and potentially a decrease in efficacy.Mesalazine may increase the hypoglycemic activities of Tirzepatide.The risk or severity of hypoglycemia can be increased when Metformin is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Tirzepatide.Methyl salicylate may increase the hypoglycemic activities of Tirzepatide.The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Metolazone.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Metoprolol.Tirzepatide can cause a decrease in the absorption of Mifepristone resulting in a reduced serum concentration and potentially a decrease in efficacy.The risk or severity of hypoglycemia can be increased when Miglitol is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Milnacipran is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Moxifloxacin.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Nadolol.The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Nebivolol.The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Nelfinavir.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Niacin.The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Nilotinib.The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Tirzepatide.Tirzepatide can cause a decrease in the absorption of Norethisterone resulting in a reduced serum concentration and potentially a decrease in efficacy.Tirzepatide can cause a decrease in the absorption of Norgestimate resulting in a reduced serum concentration and potentially a decrease in efficacy.Tirzepatide can cause a decrease in the absorption of Norgestrel resulting in a reduced serum concentration and potentially a decrease in efficacy.Nortriptyline may decrease the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Octreotide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Ofloxacin.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Olanzapine.Olsalazine may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Paliperidone.The risk or severity of hypoglycemia can be increased when Paroxetine is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Pasireotide.The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Pentamidine.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Phentermine.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Phenytoin.The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Pindolol.The risk or severity of hypoglycemia can be increased when Pioglitazone is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Polythiazide.The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Prednisone is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Progesterone.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Propafenone.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Propranolol.Protriptyline may decrease the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Pseudoephedrine.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Quetiapine.The risk or severity of hypoglycemia can be increased when Quinine is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Risperidone.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Ritonavir.The risk or severity of hypoglycemia can be increased when Rosiglitazone is combined with Tirzepatide.Salicylic acid may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Saquinavir.The risk or severity of hypoglycemia can be increased when Saxagliptin is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Semaglutide is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Sertraline is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Sirolimus.The risk or severity of hypoglycemia can be increased when Sitagliptin is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Somapacitan.Somatotropin may decrease the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Somatrogon.The risk or severity of hypoglycemia can be increased when Sotagliflozin is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Sotalol is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Sulfamethoxazole is combined with Tirzepatide.Sulfasalazine may increase the hypoglycemic activities of Tirzepatide.The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Tacrolimus.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Temsirolimus.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Teprotumumab.Thyroid, porcine may decrease the hypoglycemic activities of Tirzepatide.Thyrotropin alfa may decrease the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Timolol.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Tipranavir.The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Tolazamide is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Torasemide.The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Tirzepatide.Trimipramine may decrease the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Triptorelin.Trolamine salicylate may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Trovafloxacin.The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Verapamil is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Vorinostat.The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Tirzepatide.The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Ziprasidone.The risk or severity of hypoglycemia can be increased when Zonisamide is combined with Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Acetazolamide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Acetyl sulfisoxazole.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Albuterol.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Bosentan.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Celecoxib.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Diclofenamide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Fedratinib.Fluoxymesterone may increase the hypoglycemic activities of Tirzepatide.Isocarboxazid may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Levothyroxine.Linezolid may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Lithium carbonate.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Methazolamide.Methylene blue may increase the hypoglycemic activities of Tirzepatide.Methyltestosterone may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Mitapivat.Nandrolone decanoate may increase the hypoglycemic activities of Tirzepatide.Oxandrolone may increase the hypoglycemic activities of Tirzepatide.Oxymetholone may increase the hypoglycemic activities of Tirzepatide.Phenelzine may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Probenecid.Procaine may increase the hypoglycemic activities of Tirzepatide.Procarbazine may increase the hypoglycemic activities of Tirzepatide.Rasagiline may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Rosuvastatin.Safinamide may increase the hypoglycemic activities of Tirzepatide.Selegiline may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Sulfamethizole.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Sumatriptan.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Tamsulosin.Testosterone may increase the hypoglycemic activities of Tirzepatide.Testosterone cypionate may increase the hypoglycemic activities of Tirzepatide.Testosterone enanthate may increase the hypoglycemic activities of Tirzepatide.Testosterone propionate may increase the hypoglycemic activities of Tirzepatide.Testosterone undecanoate may increase the hypoglycemic activities of Tirzepatide.Tranylcypromine may increase the hypoglycemic activities of Tirzepatide.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Valdecoxib.The therapeutic efficacy of Tirzepatide can be increased when used in combination with Vemurafenib.
A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and Mounjaro®.
Acarbose
Acebutolol
Acetylsalicylic acid
Alclometasone
Alogliptin
Amcinonide
Aminosalicylic acid
Amiodarone
Amitriptyline
Amlodipine
Amoxapine
Aripiprazole
Arsenic trioxide
Articaine
Asenapine
Atazanavir
Atenolol
Baclofen
Balsalazide
Beclomethasone dipropionate
Benazepril
Bendroflumethiazide
Betamethasone
Betaxolol
Bexagliflozin
Bismuth subsalicylate
Bisoprolol
Brexpiprazole
Bromocriptine
Budesonide
Bumetanide
Canagliflozin
Carvedilol
Ceritinib
Chlorothiazide
Chlorpromazine
Chlorthalidone
Choline salicylate
Ciclesonide
Ciprofloxacin
Citalopram
Clevidipine
Clobetasol propionate
Clocortolone
Clomipramine
Clozapine
Conjugated estrogens
Corticotropin
Cortisone acetate
Dabrafenib
Danazol
Dapagliflozin
Darunavir
Deflazacort
Delafloxacin
Desipramine
Desogestrel
Desonide
Desoximetasone
Desvenlafaxine
Dexamethasone
Dexamethasone acetate
Diazoxide
Dienogest
Diflorasone
Diflunisal
Difluprednate
Diltiazem
Disopyramide
Doxepin
Drospirenone
Dulaglutide
Duloxetine
Empagliflozin
Epinephrine
Ertugliflozin
Escitalopram
Estetrol
Estradiol
Estrone sulfate
Etacrynic acid
Ethinylestradiol
Ethosuximide
Ethynodiol diacetate
Etonogestrel
Everolimus
Exenatide
Felodipine
Fluconazole
Fludrocortisone
Flunisolide
Fluocinolone acetonide
Fluocinonide
Fluorometholone
Fluoxetine
Flurandrenolide
Fluticasone furoate
Fluticasone propionate
Fluvoxamine
Fosamprenavir
Furosemide
Gatifloxacin
Gemifloxacin
Gestodene
Glimepiride
Glipizide
Glyburide
Goserelin
Halcinonide
Haloperidol
Histrelin
Hydrochlorothiazide
Hydrocortisone
Hydrocortisone acetate
Hydrocortisone butyrate
Hydrocortisone probutate
Hydrocortisone succinate
Hydrocortisone valerate
Hydroflumethiazide
Hydroxychloroquine
Hydroxyprogesterone caproate
Iloperidone
Imipramine
Indapamide
Indinavir
Indomethacin
Insulin aspart
Insulin degludec
Insulin detemir
Insulin glargine
Insulin glulisine
Insulin human
Insulin lispro
Isoniazid
Isradipine
Labetalol
Lanreotide
Leuprolide
Levamlodipine
Levofloxacin
Levomilnacipran
Levonorgestrel
Linagliptin
Liothyronine
Lipoic acid
Liraglutide
Lixisenatide
Lomefloxacin
Lonapegsomatropin
Lopinavir
Lurasidone
Magnesium sulfate
Mecasermin
Medroxyprogesterone acetate
Medrysone
Megestrol acetate
Mesalazine
Metformin
Methsuximide
Methyl salicylate
Methylprednisolone
Methylprednisolone hemisuccinate
Metolazone
Metoprolol
Mifepristone
Miglitol
Milnacipran
Mometasone furoate
Moxifloxacin
Nadolol
Nateglinide
Nebivolol
Nefazodone
Nelfinavir
Niacin
Nicardipine
Nifedipine
Nilotinib
Nimodipine
Nisoldipine
Norethisterone
Norgestimate
Norgestrel
Nortriptyline
Octreotide
Ofloxacin
Olanzapine
Olsalazine
Paliperidone
Paroxetine
Pasireotide
Pegvisomant
Pentamidine
Phentermine
Phenytoin
Pinaverium
Pindolol
Pioglitazone
Polythiazide
Pramlintide
Prednicarbate
Prednisolone
Prednisolone acetate
Prednisolone phosphate
Prednisone
Pregabalin
Progesterone
Propafenone
Propranolol
Protriptyline
Pseudoephedrine
Quetiapine
Quinine
Repaglinide
Risperidone
Ritonavir
Rosiglitazone
Salicylic acid
Saquinavir
Saxagliptin
Semaglutide
Sertraline
Sirolimus
Sitagliptin
Somapacitan
Somatotropin
Somatrogon
Sotagliflozin
Sotalol
Sulfadiazine
Sulfamethoxazole
Sulfasalazine
Sunitinib
Tacrolimus
Temsirolimus
Teprotumumab
Thyroid, porcine
Thyrotropin alfa
Timolol
Tipranavir
Tixocortol
Tolazamide
Torasemide
Triamcinolone
Trimipramine
Triptorelin
Trolamine salicylate
Trovafloxacin
Ubidecarenone
Ulobetasol
Vamorolone
Venlafaxine
Verapamil
Vorinostat
Xylometazoline
Ziconotide
Ziprasidone
Zonisamide
Acetazolamide
Acetyl sulfisoxazole
Albuterol
Bosentan
Celecoxib
Diclofenamide
Fedratinib
Fluoxymesterone
Isocarboxazid
Levothyroxine
Linezolid
Lithium carbonate
Methazolamide
Methylene blue
Methyltestosterone
Mitapivat
Nandrolone decanoate
Oxandrolone
Oxymetholone
Phenelzine
Probenecid
Procaine
Procarbazine
Rasagiline
Rosuvastatin
Safinamide
Selegiline
Sulfamethizole
Sumatriptan
Tamsulosin
Testosterone
Testosterone cypionate
Testosterone enanthate
Testosterone propionate
Testosterone undecanoate
Tranylcypromine
Valdecoxib
Vemurafenib